Share
Print

Cedars-Sinai Medical Center

Total Awards:

11

ICOC Committed funds:

33 682 007

Awards to the Institution

			Funding
Tools and Technologies II:	Clive Svendsen	Use of iPS cells (iPSCs) to develop novels tools for the treatment of spinal muscular atrophy.	$1,933,022
Early Translational II:	Dan Gazit	Systemic Adult Stem Cell Therapy for Osteoporosis-Related Vertebral Compression Fractures	$1,927,698
Disease Team Research I:	Eduardo Marbán	Autologous cardiac-derived cells for advanced ischemic cardiomyopathy	$5,560,232
Disease Team Therapy Planning I:	Dan Gazit	Genetically Engineered Mesenchymal Stem Cells for the Treatment of Vertebral Compression Fractures.	$109,743
Disease Team Therapy Planning I:	Clive Svendsen	Stem Cells Secreting GDNF for the Treatment of ALS	$89,834
Transplantation Immunology:	Terrence Town	Role of HLA in neural stem cell rejection using humanized mice	$1,472,634
Disease Team Therapy Development - Research:	Clive Svendsen	Progenitor Cells Secreting GDNF for the Treatment of ALS	$17,842,617
iPSC Consortia Award:	Clive Svendsen	The HD iPSC Consortium: Repeat Length Dependent Phenotypes for Assay Development	$300,000
Basic Biology IV:	Eduardo Marbán	Mechanism of heart regeneration by cardiosphere-derived cells	$1,367,604
New Faculty Physician Scientist:	Robert Baloh	Human iPSC modeling and therapeutics for degenerative peripheral nerve disease	$3,031,737
Research Leadership 12:	Barry Stripp	Epithelial progenitors and the stromal niche as therapeutic targets in lung disease	$4,841,830
Disease Team Planning:	Eduardo Marbán	{REDACTED} Heart Disease Regenerative Medicine Team Planning Award	$46,886
			Total: $38,523,837.00

© 2013 California Institute for Regenerative Medicine